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Objective: To validate the Glasgow Aneurysm Score (GAS) in patients with ruptured abdominal aortic aneurysms (AAAs)
treated with endovascular repair or open surgery and to update the GAS so that it predicts 30-day mortality for patients
with ruptured AAA treated with endovascular repair or open surgery.
Methods: In a multicenter prospective observational study, 233 consecutive patients with ruptured AAAs were evaluated; 32
patients did not survive to repair and statistical analysis was performed using collected data on 201 patients. All patients who
were treated with endovascular repair (n  58) or open surgery (n  143) were included. The GAS was calculated for each
patient. The area under the receiver operating characteristics curve (AUC)was used to indicate discriminative ability.We tested
for interactions between risk factors and the procedure performed. The GAS was updated to predict 30-day mortality after
endovascular repair or open surgery in patients with ruptured AAAs using logistic regression analysis.
Results: Thirty-day mortality was 15/58 (26%) for patients treated with endovascular repair and 57/143 (40%) for
patients treated with open surgery (P  .06). The AUC for GAS was 0.69. No relevant interactions were found. The
updated prediction rule (AUC 0.70) can be calculated with the following formula: 7 for open surgery age in years
17 for shock  7 for myocardial disease  10 for cerebrovascular disease  14 for renal insufficiency.
Conclusion: We showed limited discriminative ability of the GAS and therefore updated the GAS by adding the type of
procedure performed. This updated prediction rule predicts 30-day mortality for patients with ruptured AAAs treated
with endovascular repair or open surgery. (J Vasc Surg 2009;49:1093-9.)The traditional approach to treat ruptured abdominal
aortic aneurysms (AAAs) is open surgery. The Glasgow
Aneurysm Score (GAS) is used to predict in-hospital mor-
tality after open surgery for patients with ruptured or
unruptured AAA.1 Several studies have validated this pre-
diction rule in patients with ruptured AAA treated with
open surgery. Two validations reported good validity2,3
and two reported poor validity.4,5
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doi:10.1016/j.jvs.2008.12.027Since 1994, endovascular repair for ruptured AAAs has
been proven to be feasible6 and is increasingly being
adopted as the treatment of choice.7 Several studies showed
a reduction in mortality and morbidity rates after endovas-
cular repair compared to rates for open surgery in patients
with ruptured AAAs;8-11 however, in other studies this
reduction could not be confirmed.12-14 Recently, it was
suggested that patients at higher risk for periprocedural
cardiac complications may benefit more from endovascular
repair than from open surgery.14
Due to the rise of endovascular repair, the patient
population receiving open surgery has shifted in recent
years and the GAS may no longer be valid in this popula-
tion. Additionally, the GAS cannot be used to decide
whether a patient with a ruptured AAA may benefit more
from endovascular repair or from open surgery, as it does
not predict outcomes for endovascular repair patients. Sev-
eral studies investigated whether the GASwas a predictor of
outcomes in patients with elective endovascular AAA repair
and their results were contradictive.15-18 One study at-
tempted to define cut-off values of the GAS to be able to
determine if patients with elective AAA should be treated
with endovascular or open repair.19 Furthermore, one
study found that the GAS was of limited value in patients
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the current GAS prediction rule is still valid in predicting
30-day mortality after open surgery and whether it can
predict 30-day mortality after endovascular repair needs to
be determined. Ideally, the GAS should be modified to
identify patients who would be better suited for endovas-
cular repair vs open surgery.
The purpose of our study was to validate the GAS in
patients with ruptured AAAs who were treated with endo-
vascular repair or open surgery. In addition, we aimed to
update the GAS for prediction of 30-day mortality after
endovascular repair or open surgery.
METHODS
Patient population. In a prospective multicenter ob-
servational study, data were collected on 233 consecutive
patients between December 22, 2004, and October 31,
2006, in seven institutions in The Netherlands: Atrium
Medical Center, Heerlen (45 patients), CatharinaHospital,
Eindhoven (25 patients), ErasmusMedical Center, Rotter-
dam (40 patients), Medical Spectrum Twente, Enschede
(24 patients), Medical Center Rotterdam Zuid, Rotterdam
(30 patients), University Medical Center, Groningen (37
patients), and University Medical Center, Nijmegen (32
patients). Patients were included if they presented with
ruptured AAAs and were treated with endovascular repair
or open surgery (n  201). A total of 32 of 233 patients
(14%) were excluded because they died before AAA repair
could be initiated; death was caused by severe comorbidity
or the patient refused treatment (Fig 1). Rupture of the
AAA was confirmed on computed tomography (CT) scan
prior to the procedure, or by free blood noted during
laparotomy. The Institutional Review Board approved this
study and waived the obligation to obtain informed con-
sent due to the acute nature of the clinical problem and the
observational nature of this study.20
Protocol. In all participating hospitals, endovascular
Fig 1. Patient flowchart.repair was the preferred treatment in patients with rupturedAAA. Except for in one hospital, the vascular surgeon and/or
radiologist who performed endovascular repair of ruptured
AAAs were available 24 hours a day, 7 days a week. Upon
arrival in thehospital, patientswhowere in a hemodynamically
stable condition underwent an abdominalCT-scan to confirm
rupture and to assess whether the AAA was anatomically
suited for endovascular repair. In 4 patients, an additional
aortic angiography was performed to assess anatomic suitabil-
ity for endovascular repair. If patients were anatomically suit-
able for endovascular repair, they were treated with this pro-
cedure. Hemodynamically unstable patients (n  37) were
immediately transported to the operating room for open
surgery. The definition of “hemodynamically stable” was de-
termined upon arrival at the hospital and varied across the
participatinghospitals. In twohospitals, the attending vascular
surgeon made the judgment without explicit criteria. In two
other hospitals, the attending vascular surgeon or radiologist
considered the patient hemodynamically stable if s/he gave an
adequate verbal reply. In one hospital, the attending vascular
surgeon defined hemodynamically stable as a systolic blood
pressure of 60 millimeter Mercury or higher, whereas in two
other hospitals a systolic blood pressure cutoff of 70 millime-
ter Mercury was used. After CT-scan confirmed the presence
of a ruptured AAA, the patient was immediately transported
to the operating room where endovascular repair was per-
formed if the AAA was anatomically suitable; otherwise, open
surgery was performed. The anatomic inclusion criteria for
endovascular repair differed between the participating hospi-
tals since they stocked different endovascular devices. The
criteria varied between 7 and 15 millimeters for the proximal
neck length, between 30° and 90° for the neck angulation,
and between 28 and 32 millimeters for the neck diameter.
The endografts used were Talent aortouniiliac (AUI) stent-
grafts (Medtronic, Santa Rosa, Calif), Anaconda bifurcated
endografts (Vascutek, Renfrewshire, Scotland), Cook en-
dografts (Zenith, Bloomington, Ind), and Excluder en-
dografts (Gore, Flagstaff, Ariz).
Data collection and definitions. Prospectively col-
lected data included: patient characteristics (ie, age, gender,
renal insufficiency, and history of diabetes mellitus, hyper-
tension, angina pectoris, myocardial infarction, congestive
heart failure, or cerebrovascular disease), use of medication
prior to hospital admission, patients’ hemodynamic condi-
tion upon presentation to the hospital, shock upon presen-
tation to the hospital, use of CT-scan or angiography prior
to the procedure, morphology of the AAA (infrarenal,
juxtarenal, or suprarenal), time to repair, and which treat-
ment was performed (endovascular repair or open surgery).
Diabetes mellitus was defined as receiving oral medication
and/or insulin therapy for diabetes mellitus. Hypertension
included patients with receipt of at least one antihyperten-
sive drug. Congestive heart failure included symptoms of
congestive heart failure and receipt of medication for this
diagnosis. Shock was defined as a systolic blood pressure
less than 80 millimeter Mercury based on the lowest blood
pressure recorded. Myocardial disease comprised previous
myocardial infarction and/or angina pectoris. Cerebrovas-
cular disease included all previous cerebrovascular accidents
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 5 Visser et al 1095and transient ischemic attacks. Renal insufficiency referred
to a preoperative creatinine value of more than 160 micro-
mols per liter (ie, 1.8 milligrams per deciliter). Data on
AAA neck length, neck diameter, and neck angulation was
not collected. A standardized form was used to register
these data. In order to obtain information about 30-day
mortality and the causes of death, medical records, and the
computerized database of the participating hospitals were
used. The data was prospectively gathered and retrospec-
tively analyzed.
Glasgow Aneurysm Score. The GAS was originally
based on 235 patients treated for AAA between January
1980 and December 1989 at four hospitals in Glasgow,
United Kingdom.1 The GAS was calculated using the
following formula: GAS age in years 17 for shock 7
for myocardial disease  10 for cerebrovascular disease 
14 for renal insufficiency.1 Patients with a GAS less than 70
are considered to have a low risk of mortality after open
surgery for AAA, whereas patients with a GAS more than
85 are considered to have a high risk of mortality after
treatment for AAA. In the original paper, ‘shock’ was based
on clinical information of tachycardia, hypotension, pallor,
and sweating. Myocardial disease was defined as previous
myocardial infarction and/or angina pectoris. Cerebrovas-
cular disease comprised all grades of stroke including tran-
sient ischemic attacks. Renal insufficiency included chronic
and acute renal failure.1
Data and statistical analyses. Patient data were en-
tered into a database and checked by one of the authors for
completeness (J. J. V.). Missing data regarding continuous
variables (ie, age and systolic blood pressure) were assumed
to be missing at random and entered based on the variable
means since the number of missing values is low.21 If data
regarding patient’s medical history or medication were
missing, it was assumed that the risk factor was not present
or the medication was not used. In total, the proportion of
missing data was less then 2% before missing data was
entered. Analyses were performed according to the inten-
tion-to-treat principle; therefore, intraoperative deaths
were also included for analysis in the respective treatment
group.
We validated the GAS using receiver operating charac-
teristics (ROC) curves to determine discriminative ability
(ie, whether the GAS was higher in patients who died). An
area under the ROC curve (AUC) of 0.50 indicates no
discriminative ability and the closer the AUC is to 1.0, the
better the discriminative ability.
In addition, we tested for interactions between risk
factors (as determined in the GAS model) and the specific
procedure performed in predicting 30-day mortality using
logistic regression analysis. Interaction terms were consid-
ered potentially relevant if P  .20.
Based on a previously published approach, the GASwas
updated to predict 30-day mortality after either endovas-
cular repair or open surgery.22 In the first step, we esti-
mated new regression coefficients for the GAS variables
based on the study data. In the second step, we added the
procedure performed (open surgery vs endovascular repair)to the original GAS variables.22 Regression coefficients for
the new variable (ie, the procedure) and an intercept term
were estimated; the GAS was then multiplied by a calibra-
tion slope GAS for overall adjustment of the original GAS
regression coefficients. The formula we used was (30-day
mortality)study dataprocedure * (procedure)GAS *
GAS. To calculate the adjusted GAS odds ratios, we used
the formula: (adjusted GAS odds ratio)  (original GAS
odds ratio) * exp (GAS). In the third step, we performed a
multivariable logistic regression analysis on 30-day mortal-
ity, including the procedure performed (open surgery vs
endovascular repair) and all individual GAS variables (ie,
age, shock, myocardial disease, cerebrovascular disease, and
renal insufficiency), and we estimated new regression coef-
ficients for each variable.22 For each step, the AUC was
estimated as ameasure of discriminative ability and adjusted
for optimism by bootstrapping. We used 200 bootstrap
samples drawn with replacement from the original dataset.
Bootstrapping means random drawing from the original
data with replacement. This is a method to assess statistical
accuracy. This validation procedure indicates the perfor-
mance that may be expected in new, but similar patients.23
The AUCs from the first, second, and third step were
compared, and the prediction rule with the highest AUC is
presented as the updated prediction rule.
Analyses were performed using SPSS for Windows Ver-
sion 11.0.1 (SPSS Inc., Chicago, Ill) and S-Plus Version
6.0 (Insightful Corporation, Seattle, Wash).
RESULTS
Patient population. Patient demographics, charac-
Table I. Patient demographics and characteristics
Endovascular
repair
Open
surgery
n  58 n  143 P value
Male 54 (93%) 118 (83%) .05
Mean age (SD) 73.2 (8.6) 73.5 (7.5) .83
Renal insufficiency 8 (14%) 16 (11%) .61
Diabetes mellitus 8 (14%) 13 (9%) .32
Hypertension 29 (50%) 60 (42%) .30
Angina pectoris 6 (10%) 18 (13%) .66
Previous myocardial
infarction 12 (21%) 35 (25%) .57
Heart failure 6 (10%) 14 (10%) .91
CVA/TIA 6 (10%) 18 (13%) .66
COPD 15 (26%) 30 (21%) .45
AAA known before
admission 14 (24%) 25 (18%) .28
Shock 4 (7%) 40 (28%) .001
Medication
Beta-blocker 19 (33%) 40 (28%) .50
Anticoagulants 11 (19%) 17 (12%) .19
Antiplatelet agents 24 (41%) 46 (32%) .21
Statins 18 (31%) 27 (19%) .06
SD, Standard deviation; CVA, cerebrovascular accident; TIA, transient
ischemic attacks; COPD, chronic obstructive pulmonary disease; AAA,
abdominal aortic aneurysm.teristics, and use of medication before admission are listed
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patients treated with endovascular repair compared with
patients treated with open surgery (93% vs 83%, P  .05).
In addition, the use of statins was somewhat higher in
patients treated with endovascular repair compared with
patients treated with open surgery (31% vs 19%, P  .06).
The other characteristics were similar between the treat-
ment groups. Eighty-three of the 143 patients (58%)
treated with open surgery had infrarenal AAAs, 49 (34%)
had juxtarenal (ie, no infrarenal neck) AAAs, 4 (3%) had
suprarenal AAAs, and in 7 patients (5%) the AAA anatomy
was not reported.
Outcomes. Thirty-day mortality was 15/58 (26%) for
patients treated with endovascular repair and 57/143
(40%) for patients treated with open surgery (P  .06).
Among patients who were treated with open surgery, 30-
day mortality was 39/106 (37%) for those who were he-
modynamically stable prior to the procedure and 18/37
(49%) for those who were hemodynamically unstable prior
to the procedure (P  .20). Two of the 58 patients (3%)
treated with endovascular repair died intraoperatively,
while 21 of the 143 patients (15%) treated with open
surgery died intraoperatively (P  .02). There was no
statistically significant association between the time to re-
pair and 30-day mortality. The causes of 30-day mortality
are listed in Table II. The difference in 30-daymortality was
approximately similar to the difference in intraoperative
mortality. Nine of the 58 patients (16%) initially treated
with endovascular repair were converted to open surgery.
The reasons for conversion to open surgery were the en-
dografts could not be positioned correctly in the infrarenal
neck (n 1), colon ischemia (n 1), large hematoma with
Table II. Causes of 30-day mortality
Endovascular
repair Open surgery
n  58 n  143
Intraoperative 2 (3%) 21 (15%)
Postoperative
Cardiovascular* 3 (5%) 8 (6%)
Pulmonary
†
3 (5%) 5 (3%)
Renal failure 1 (2%) 1 (1%)
Sepsis 2 (3%) 1 (1%)
Shock
‡
2 (3%) 4 (3%)
Coagulopathy 1 (2%) 0 (0%)
Multiorgan failure 1 (2%) 4 (3%)
Infection 0 (0%) 1 (1%)
No treatment due to patients’
comorbidity
§
0 (0%) 3 (2%)
Unknown 0 (0%) 9 (6%)
Total deaths 15 (26%) 57 (40%)
*Cardiac causes of death included ventricular fibrillation, myocardial isch-
emia, progressive heart failure with fatal outcome, continuous hypotension,
and cardiac arrest.
†Pulmonary causes of death included acute respiratory distress syndrome,
pulmonary embolism, and respiratory insufficiency.
‡Shock included septic shock, hypovolemic shock, and cardiac shock.
§Due to patients’ comorbidity, no further medical support was given.abdominal compartment (n  4), and unknown (n  3).Validation of GAS. The GAS was less than 70 in 42
patients; between 70 and 75 in 26 patients; between 76 and
85 in 58 patients; and more than 85 in 75 patients (Table
III). The mean GAS among patients who survived 30 days
after the initial procedure was 77 for patients treated with
endovascular repair and 80 for patients treated with open
surgery (P  .14). The mean GAS among patients who
died within 30 days after the initial procedure was 87 for
patients treated with endovascular repair and 88 for pa-
tients treated with open surgery (P  .81). The AUC for
the GAS was 0.69 (95%-confidence interval 0.61-0.76).
Interaction. Testing for interaction between risk fac-
tors and the type of procedure performed on 30-day mor-
tality showed no relevant interactions (all P values  .20).
This means that no risk factors were associated with a
higher mortality for a specific procedure. Instead, endovas-
cular repair always favored open surgery with respect to
30-day mortality given the set of risk factors included in the
GAS model.
Updated prediction rule. In the first step, we esti-
mated new regression coefficients for the GAS variables
based on the study data. The AUC adjusted for optimism
was 0.67 (Table IV). In the second step, we added one new
variable to the original GAS variables: the type of procedure
performed (open surgery vs endovascular repair). The esti-
mation of the intercept, regression coefficients, and calibra-
tion slope led to the following formula: (30-day morta-
lity)study data   5.30  0.50 * (procedure)  0.052 *
GAS. The AUC adjusted for optimism was 0.70. The
adjusted GAS odds ratios are listed in Table IV. In the third
step, the type of procedure performed (open surgery vs
endovascular repair) was added to the GAS variables, and
new regression coefficients were estimated for each vari-
able. The AUC was adjusted for optimism by bootstrapping
and was 0.68. Since the second model had the highest opti-
mism-
corrected AUC, we used it to calculate the updated GAS.
Multiplication with the weights in the original GAS and
rounding gives the following risk score:
Updated GAS 7 for open surgery age in years 17
for shock 7 for myocardial disease 10 for cerebro-
vascular disease  14 for renal insufficiency.
Table V shows an example of how to calculate the
30-day mortality for a patient with a ruptured AAA for
endovascular repair or open surgery. Fig 2 shows the 30-
day mortality depending on the updated GAS.
DISCUSSION
Policies for treatment of AAA have changed since the
introduction of endovascular repair for patients with rup-
tured AAA. Patients who are hemodynamically stable re-
ceive a CT-scan and some an additional angiography prior
to the procedure to assess anatomic eligibility for endovas-
cular repair. Those who are too hemodynamically unstable
to undergo imaging are immediately transported to the
operating room for open surgery. Therefore, in this pro-
spective multicenter study we aimed to validate the GAS
trans
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surgery and in those treated with endovascular repair. Fur-
thermore, we updated the GAS to predict 30-day mortality
after either endovascular repair or open surgery in patients
with ruptured AAA. We found that the GAS showed lim-
ited discriminative ability in our patient population. In
addition, we showed that, considering the included risk
factors, 30-day mortality was always lower if patients with
Table III. GAS and the prediction of 30-day mortality
Endovascular repair
Score Number of patients Mortality (%)
 70 17 2 (12%)
70-75 8 2 (25%)
76-85 16 3 (19%)
 85 17 8 (47%)
Total 58 15 (26%)
GAS, Glasgow Aneurysm Score; CI, confidence interval.
*Open surgery vs endovascular repair.
Table IV. Multivariable models on 30-day mortality
Variable Step 1
Procedure performed (open surgery vs
endovascular repair) —
Age (per decade) 2.39 (1.52-
Shock 1.66 (0.80-
Myocardial disease 1.76 (0.90-
Cerebrovascular disease 1.13 (0.46-
Renal disease 2.06 (0.83-
Area under the curve 0.67 (0.60-
OR, Odds ratio.
Table V. How to calculate 30-day mortality after endovas
an example of the calculation of 30-day mortality as a func
Example A 72-year-old patient with a ruptured AAA
a preoperative creatinine value of more t
Steps Formulas
1. Calculate updated
GAS
Updated GAS   7 for surgery 
age*  17 for shock
†
 7 for
myocardial disease
‡
 10 for
cerebrovascular disease
§
 14 for
renal insufficiency

Upda
7 
2. Calculate linear
predictor
Linear predictor  5.30 
0.052* Updated GAS
Linea
93
3. Calculate 30-day
mortality
30-day mortality  1 
(1/[1exp {linear predictor}])
30-da
{
AAA, Abdominal aortic aneurysm; GAS, Glasgow Aneurysm Score.
*Age in years.
†Shock was defined as a systolic blood pressure less than 80 millimeters Me
‡Myocardial disease comprised previous myocardial infarction and/or angin
§Cerebrovascular disease included all previous cerebrovascular accidents and
Renal insufficiency referred to a preoperative creatinine value more of thanruptured AAA were treated with endovascular repair asopposed to open surgery. This means that no risk factors
were associated with a higher mortality for a specific proce-
dure. Furthermore, the advantage for endovascular repair
appeared to be caused by difference in intraoperative mor-
tality.
The limited discriminative ability of the GAS may be
due to the introduction of endovascular repair in patients
with ruptured AAA. When the GAS was developed, open
Open surgery
Odds ratio*
(95%-CI)mber of patients Mortality (%)
25 3 (12%) 1.02 (0.15-6.9)
18 7 (39%) 1.91 (0.30-12)
42 17 (41%) 2.95 (0.73-12)
58 30 (52%) 1.21 (0.41-3.6)
143 57 (40%) 1.90 (0.97-3.7)
OR (95%-confidence interval)
Step 2 Step 3
1.65 (0.81-3.35) 1.93 (0.92-4.03)
2.21 (1.18-4.13) 2.44 (1.52-3.90)
3.82 (2.29-6.38) 1.44 (0.68-3.05)
1.81 (1.13-2.89) 1.74 (0.88-3.42)
2.20 (1.19-4.07) 1.13 (0.45-2.81)
3.03 (1.55-5.89) 2.17 (0.87-5.41)
0.70 (0.62-0.77) 0.68 (0.61-0.75)
repair or open surgery for patients with ruptured AAA;
of the updated GAS
is not in shock, previously had a myocardial infarction, and has
60 micromols per liter.
dovascular repair Open surgery
AS   0  72  0 
14  93
Updated GAS   7  72  0 
7  0  14  100
dictor  5.30  0.052*
0.46
Linear predictor  5.30  0.052*
100  0.10
rtality  1  (1/[1exp
])  0.39
30-day mortality  1  (1/[1exp
{0.10}])  0.48
toris.
ient ischemic attacks.
icromols per liter (ie, 1.8 milligrams per deciliter).Nu3.75)
3.45)
3.44)
2.80)
5.06)
0.74)cular
tion
, who
han 1
En
ted G
0 
r pre
 
y mo
0.46}
rcury.
a pecsurgery was the only treatment for ruptured AAAs. The
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factors not involved in the GAS influenced mortality after
repair for ruptured AAA. In addition, in the evaluation of
predictive values of the GAS, we found that patients with a
high GAS would benefit less from endovascular repair. This
is not consistent with previous findings, suggesting that
patients at higher risk for periprocedural cardiac complica-
tions would benefit more from endovascular repair than
those at lower risk.14 It should be noted, however, that
confidence intervals surrounding the odds ratios were wide.
In the updated GAS, we added one new variable to the
GAS variables: the type of procedure performed. It turned
out that patients who were in shock prior to the procedure
had lower 30-daymortalities than those whowere not. This
may be due to selection criteria since patients not in shock
are expected to have lower 30-day mortalities than those
who are in shock and, therefore, were immediately trans-
ported to the operating room for open surgery.7 Similar to
patients not in shock, patients in shock might better un-
dergo endovascular repair than open surgery if the anatomy
allows. Therefore, it remains to be clarified whether pa-
tients in shock should undergo imaging prior to the proce-
dure, althoughmost patients appear to be sufficiently stable
to do so.24
Furthermore, the updated GAS showed that patients
who underwent endovascular repair had lower 30-day mor-
talities than those who underwent open surgery. Again, this
may be due to selection criteria since endovascular repair
patients were mostly not in shock, while 28% of open
surgery patients were. In addition, the interaction terms
between GAS variables and the therapeutic procedure per-
formed were not associated with 30-day mortality meaning
that no risk factors were associated with a higher mortality
for a specific procedure. Instead, endovascular repair always
favored open surgery with respect to 30-daymortality given
the set of risk factors included in the GAS model. Further-
more, we found no statistically significant association be-
tween the time to repair and 30-day mortality. Therefore,
the delay due to performing a CT-scan may have limited
Fig 2. The 30-daymortality as a function of the updatedGlasgow
Aneurysm Score (GAS) for patients with a ruptured abdominal
aortic aneurysm undergoing either endovascular or open repair.influence on mortality.Two studies that validated GAS in patients with rup-
tured AAA treated with open surgery reported better valid-
ity than our study,2,3 and two studies reported worse
validity.4,5 It should be noted that these studies were
performed in patients treated with open surgery, whereas in
our study patients treated with open surgery as well as
patients treated with endovascular repair were included.
Studies that investigated the performance of the GAS in
patients with elective AAA did not show consistent re-
sults.15-19
Our study had several limitations. The definitions of
risk factors were slightly different from the original GAS. In
addition, since the intent is for the model to be predictive,
the GAS only included patient characteristics that can be
known upon patients’ presentation to the hospital or
shortly thereafter. Consequently, we did not collect data on
the AAA anatomy, such as neck length, neck diameter, and
neck angulation. Furthermore, our prediction rule is not
based on a randomized controlled trial, and the selection
for endovascular repair was based on patients’ hemody-
namic condition and AAA eligibility for endovascular re-
pair. Therefore, selection bias may have affected our results
in favor of endovascular repair and the updated GAS may
not be generalizable to all practice settings. The data we
used, however, were based on patients who were seen
consecutively, and our study represents current clinical
practice. Also, we had a small sample; therefore, lack of
statistical power may have affected our results.
The treatment protocols between the participating
hospitals were slightly different. The criteria for patients
being hemodynamically (un)stable differed across the hos-
pitals. In addition, the types of endografts used were not
the same in all hospitals. As a result, different anatomic
criteria were applied across the participating hospitals. It
should be noted that in practice, physicians tend to apply
more lenient criteria for endovascular repair in case of
severe comorbidity in order to avoid open surgery. In order
to implement a more uniform treatment policy for patients
with ruptured AAAs, similar protocols are needed in the
different hospitals. In addition, these protocols enable
more precise comparison of endovascular repair with open
surgery across the different hospitals.
We recommend ongoing prospective observational and
randomized controlled trials in patients with ruptured
AAA. Prospective observational studies reflect daily practice
and changes in treatment policy over time.25,26 This is of
particular interest in this group of patients, since new types
of endografts, which allow for more lenient anatomic cri-
teria, are rapidly becoming available. Randomized con-
trolled trials are needed in order to assess associations
between risk factors, the procedure performed, 30-day
mortality, and to avoid selection bias. New technologies are
only proven in a randomized fashion. If such data are not
available, as is the case here, it is ethically correct to ran-
domize patients, since in observational studies biases are
likely to be an issue. Furthermore, future studies should
investigate which patients should go immediately to the
operating room for open surgery and which patients should
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determine anatomic eligibility for endovascular repair. In
addition, since patient populations may change over time,
the development of a prediction tool is an ongoing process;
therefore, we encourage further validation and updating of
our prediction rule.
CONCLUSION
In conclusion, we showed limited discriminative
ability of the GAS in patients with ruptured AAAs to be
treated with endovascular repair or open surgery. The GAS
was updated by adding the type of procedure performed,
which predicts 30-day mortality for patients with ruptured
AAAs to be treated with either endovascular repair or open
surgery.
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